Medibank Private (MPL) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Nov, 2026Growth strategy and care model
Amplar Health supports growth through health-professional-led partnerships and investments that expand access, choice and affordability across prevention, community, virtual, primary and integrated care.
Strategic focus includes scaling profitable health businesses that strengthen customer value, choice and control and catalyse health-system change.
Health trends include rising consumer control, greater emphasis on prevention, growth in lower-cost care settings and outcome-aligned care; preventive health spend is targeted to rise from under 2% to 5% of Australian health expenditure by 2030.
Prevention and diabetes care
A Myhealth trial enables GPs at selected NSW clinics to refer eligible customers directly to a type 2 diabetes program, replacing a self-referral pathway.
The program offers personalised dietitian support, up to 10 video consultations and up to 18 weeks of meal replacements at no extra cost.
The trial aims to improve access and care coordination for participants, support customer retention through personalised experiences and reduce future benefit outlays.
Integrated mental health care
A 50/50 joint venture between Aurora Healthcare and Amplar Health plans 153 mental health beds across three new hospitals in NSW and ACT, supported by a $31m initial JV investment.
The model extends inpatient care with in-home support, telehealth, care coordination, group therapy and post-discharge services; eligible privately insured patients may receive services at no additional cost, subject to excess or co-payment.
The integrated pathways aim to support long-term recovery, improve access and choice, and help match mental health resources to differing needs.
Latest events from Medibank Private
- Underlying NPAT rose 13.8% in 1H25 as private health insurance growth continued.MPL
Corporate presentation - Non-resident growth accelerates as new care models expand health offerings.MPL
Investor presentation - 1H26 profit growth supports FY30 ambitions for health earnings, market share and engagement.MPL
Corporate presentation - Operating profit up 6.7%, with 31.3% health segment growth and higher dividends.MPL
H2 2026 - Operating profit up 6%, Medibank Health profit up 28.5%, and interim dividend up 6.4%.MPL
H1 2026 - Strong financial results, board renewal, and ambitious health sector growth plans defined the AGM.MPL
AGM 2025 - Health earnings to exceed AUD 200 million and engagement to reach 10 million by FY30.MPL
Status Update - Strong financials, higher dividends, and board expansion marked this year's AGM.MPL
AGM 2024 - Underlying NPAT up 13.8% and dividend up 8.3% amid strong growth and resilient capital.MPL
H1 2025